BioMarin Pharmaceutical | Obroty



Sales Zmiana Data
Acadia Pharmaceuticals USD 264.6M 20.28M 2025-06
Agios Pharmaceuticals USD 12.45M 3.75M 2025-06
Alnylam Pharmaceuticals USD 773.69M 179.5M 2025-06
Amgen USD 9.18B 1.03B 2025-06
Bayer EUR 10.74B 3B 2025-06
Biogen USD 2.6B 170M 2025-06
BioMarin Pharmaceutical USD 825M 80M 2025-06
Gilead Sciences USD 7.1B 430M 2025-06
Incyte USD 1.06B 10M 2025-06
Insmed USD 107.4M 14.58M 2025-06
Ionis Pharmaceuticals USD 452M 320M 2025-06
Moderna USD 142M 34M 2025-06
Neurocrine Biosciences USD 687.5M 114.9M 2025-06
PTC Therapeutics USD 178.9M 11.1M 2025-06
Regeneron Pharmaceuticals USD 3.68B 650M 2025-06
Roche Holding CHF 31.64B 883M 2024-12
Sanofi EUR 10.74B 529.51M 2025-06
Sarepta Therapeutics USD 611.09M 163.81M 2025-06
Ultragenyx Pharmaceutical USD 166.5M 27.21M 2025-06
United Therapeutics USD 798.6M 4.2M 2025-06
Vertex Pharmaceuticals USD 2.96B 190M 2025-06


BioMarin Pharmaceutical Obroty - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Sep 2025.